发明名称 |
DP2 ANTAGONIST AND USES THEREOF |
摘要 |
Described herein is the DP2 antagonist [2′-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl]-acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 antagonist, or a pharmaceutically acceptable salt thereof. Also described herein are pharmaceutical compositions suitable for administration to a mammal that include the DP2 antagonist, or a pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating respiratory diseases or conditions, allergic diseases or conditions, inflammatory diseases or conditions, as well as other prostaglandin D2-dependent or prostaglandin D2-mediated diseases or conditions. |
申请公布号 |
US2016136119(A1) |
申请公布日期 |
2016.05.19 |
申请号 |
US201414468183 |
申请日期 |
2014.08.25 |
申请人 |
Brickell Biotech, Inc. |
发明人 |
Brittain Jason Edward;Stearns Brian Andrew;King Christopher David;Holme Kevin Ross |
分类号 |
A61K31/195 |
主分类号 |
A61K31/195 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutically acceptable salt of [2′-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl]-acetic acid (Compound 1), wherein the pharmaceutically acceptable salt is a calcium salt, potassium salt, sodium salt, ammonium salt, L-arginine salt, L-lysine salt, or a N-methyl-D-glucamine salt. |
地址 |
Miami FL US |